Dr. LalPath Labs Q4 Reslts: Firm posts higher profit on healthy testing demand

Its shares climbed as much as 7.8% after the results before trimming some gains to trade up about 6%. Rival Metropolis Healthcare was up about 2% and Thyrocare Technologies gained about 1%.